Fecal Immunochemical Diagnostic Tests Market to Reflect a Holistic Expansion During 2018-2028
Verfasser: yogesh on Friday, 14 December 2018Fecal immunochemical diagnostic tests are performed for screening colorectal cancer. In Fecal immunochemical diagnostic tests, an antibody is used to detect the presence of blood in stool, which bind to a blood protein called hemoglobin found in the Red Blood Corpuscles (RBC). Positive result of fecal immunochemical diagnostic tests can be sign of colorectal cancer, polyps, ulcers, or hemorrhoids. Fecal immunochemical diagnostic tests are also known as immunochemical fecal occult blood test (iFOBT) or FIT. The blood vessels are generally fragile so they can easily be damaged, where passing of stool leads to bleeding. If the fecal immunochemical diagnostic tests results are positive, and further colonoscopy is needed for further investigation.
As per the Global Cancer Observatory (GCO), colorectal cancer (CRC) is the second most common cancer in women and the third most common in men worldwide. According to an estimation from the National Cancer Institute, in 2018 colorectal cancer is projected to contribute around 8.1% of all new cancer cases with estimated deaths around 50,630, which is 8.3% of all cancer deaths caused in the U.S. As reported by the Cancer Research UK, there were 41,804 new cases of colorectal cancer in 2015 and 16,384 deaths due to colon cancer in the U.K.